Streetbeat News

Products Services

WINT

Windtree Therapeutics (NASDAQ:WINT) shares rose 18.6% after completing enrollment for its SEISMiC Extension Phase 2b study of istaroxime in early cardiogenic shock. The study aims to confirm previous positive results and explore longer dosing durations.

Portfolio Pulse from Dylan Berman

September 04, 2024 | 4:04 pm

MYGN

Myriad Genetics shares fell after the company halted the second part of its study due to disparities between the GeneSight Group and the control group.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:51 pm

BAX

Baxter Healthcare has initiated a recall of certain Volara System single-patient use circuits and blue ventilator adapter assemblies due to a disconnection risk that may prevent proper ventilation. The FDA has classified this recall as the most serious type.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:33 pm

COIN

North Korean hackers have intensified their efforts in stealing cryptocurrencies, with funds stolen nearly doubling to $1.6 billion. Centralized exchanges like DMM and BTCTurk have been targeted, and major exchanges such as Binance and Coinbase are ramping up cybersecurity measures. The Lazarus Group, linked to North Korea, remains a significant threat.

Portfolio Pulse from Murtuza Merchant

September 04, 2024 | 3:17 pm

LRCX

Recent options trading trends for Lam Research (NASDAQ:LRCX) show a significant increase in activity, with a mix of bullish and bearish sentiments. Wealthy investors or institutions are speculated to be behind these trades, indicating potential upcoming developments for the company. The options trades suggest a targeted price range of $600 to $1040 for LRCX.

Portfolio Pulse from Benzinga Insights

September 04, 2024 | 3:15 pm

BIOA

LLY

NVO

BioAge Labs Inc, a biotech company, has filed for a $100 million IPO to be listed on Nasdaq under the symbol BIOA. The company is developing obesity drugs, with its lead drug Azelaprag showing promising results in preclinical trials. BioAge plans to conduct Phase 2 trials in combination with drugs from Eli Lilly and Novo Nordisk.

Portfolio Pulse from Vandana Singh

September 04, 2024 | 3:13 pm

HLX

PXJ

SHEL

SLB

Helix Energy Solutions Group, Inc. (NYSE:HLX) has secured a multi-year agreement with Shell Offshore Inc, a unit of Shell PLC (NYSE:SHEL), to provide well intervention services in the U.S. Gulf of Mexico starting in 2025. The contract reflects improving market conditions and increased demand for Helix's services. Helix will use its Q5000 vessel and other equipment, in collaboration with Schlumberger (NYSE:SLB), to deliver integrated operations. HLX shares have gained over 4.9% in the past month.

Portfolio Pulse from Nabaparna Bhattacharya

September 04, 2024 | 3:08 pm

MRNA

Moderna has reported positive results for its mpox vaccine, which comes at a crucial time as mpox outbreaks are spreading in Africa. This development could enhance Moderna's vaccine portfolio and potentially boost its stock performance.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 3:05 pm

SOXX

SSNLF

TDIV

TSM

Taiwan Semiconductor Manufacturing Co (TSM) and Samsung Electronics expressed optimism about AI growth at the Semicon Taiwan forum. TSM raised its revenue forecast due to AI and smartphone demand, and its stock has gained 70% in the past year. Analysts have a bullish outlook on TSM with a 1-year price target of $224.29.

Portfolio Pulse from Anusuya Lahiri

September 04, 2024 | 2:58 pm

AMGN

AZN

LLY

NVO

PFE

The MHRA has found no evidence linking GLP-1 receptor agonists to suicidal thoughts or actions but will continue monitoring for severe psychiatric reactions. This news may impact companies involved in the production or sale of these drugs.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 2:52 pm